December 8, 2025December 8, 2025 Shares of Dr Reddy’s Laboratories Ltd ended flat on 8th December, even as the company announced that it has entered into a strategic collaboration and exclusive licensing agreement with Immutep SAS to develop and commercialise Eftilagimod Alfa (efti) across multiple global markets. Dr Reddy’s…
September 11, 2025September 11, 2025 Shares of Dr Reddy’s Laboratories Ltd are trading flat after touching a day’s high of Rs 1,304 on 11th September, despite the company informing the bourses that it has entered into a definitive agreement with Janssen Pharmaceutica NV (JPNV), an…
June 13, 2024June 13, 2024 Shares of Dr Reddy’s Laboratories Ltd were trading in the green and 1% higher on 13 June after the company’s subsidiary announced signing a licensing agreement with US-based Ingenus Pharmaceuticals, LLC. The agreement states that Ingenus Pharmaceuticals, LLC has granted Dr Reddy’s Laboratories, Inc.,…